DE69610310D1 - Verfahren zur identifikation von biologisch aktiven peptiden und nukleinsäuren - Google Patents
Verfahren zur identifikation von biologisch aktiven peptiden und nukleinsäurenInfo
- Publication number
- DE69610310D1 DE69610310D1 DE69610310T DE69610310T DE69610310D1 DE 69610310 D1 DE69610310 D1 DE 69610310D1 DE 69610310 T DE69610310 T DE 69610310T DE 69610310 T DE69610310 T DE 69610310T DE 69610310 D1 DE69610310 D1 DE 69610310D1
- Authority
- DE
- Germany
- Prior art keywords
- cells
- changed
- biologically active
- nucleic acids
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK62995 | 1995-06-02 | ||
PCT/DK1996/000231 WO1996038553A1 (en) | 1995-06-02 | 1996-05-31 | A method for identification of biologically active peptides and nucleic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69610310D1 true DE69610310D1 (de) | 2000-10-19 |
DE69610310T2 DE69610310T2 (de) | 2001-03-15 |
Family
ID=8095753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69610310T Revoked DE69610310T2 (de) | 1995-06-02 | 1996-05-31 | Verfahren zur identifikation von biologisch aktiven peptiden und nukleinsäuren |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP0832207B1 (de) |
JP (1) | JPH11505724A (de) |
KR (1) | KR19990022157A (de) |
AT (1) | ATE196312T1 (de) |
AU (1) | AU699568B2 (de) |
CA (1) | CA2222879A1 (de) |
DE (1) | DE69610310T2 (de) |
DK (1) | DK0832207T3 (de) |
ES (1) | ES2151167T3 (de) |
GR (1) | GR3035017T3 (de) |
PT (1) | PT832207E (de) |
WO (1) | WO1996038553A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1295952A3 (de) | 1996-01-23 | 2003-07-09 | The Board of Trustees of The Leland Stanford Junior University | Verfahren zum screenen für transdominate Effectorpeptiden und RNS molekülen |
AU777489B2 (en) * | 1996-01-23 | 2004-10-21 | Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6365344B1 (en) | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US6969584B2 (en) * | 1997-06-12 | 2005-11-29 | Rigel Pharmaceuticals, Inc. | Combinatorial enzymatic complexes |
US6700040B2 (en) * | 1998-01-16 | 2004-03-02 | Large Scale Biology Corporation | Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
EP1053317B1 (de) * | 1998-02-13 | 2006-11-02 | Köster, Hubert | Verwendung von ribozymen zur bestimmung der funktion von genen |
US7001733B1 (en) | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
GB9827152D0 (en) * | 1998-07-03 | 1999-02-03 | Devgen Nv | Characterisation of gene function using double stranded rna inhibition |
US7005423B1 (en) | 1999-07-02 | 2006-02-28 | Devgen Nv | Characterization of gene function using double stranded RNA inhibition |
EP1270746A1 (de) * | 1998-07-20 | 2003-01-02 | Inoxell A/S | Verfahren zur Erkennung von Liganden und Ziel-Biomolekülen |
ATE223971T1 (de) * | 1998-07-20 | 2002-09-15 | Inoxell As | Neue methoden zum auffinden von liganden- und ziel-biomolekülen |
CA2341156A1 (en) * | 1998-09-04 | 2000-03-16 | Zk Pharmaceuticals, Inc. | Method for selecting peptides inhibiting viral surface protein binding to cell surface receptor |
ATE269897T1 (de) * | 1999-03-29 | 2004-07-15 | Michael Blind | Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion |
WO2001075178A2 (en) * | 2000-04-04 | 2001-10-11 | Enanta Pharmaceuticals, Inc. | Methods for identifying peptide aptamers capable of altering a cell phenotype |
WO2002068630A1 (en) * | 2001-02-22 | 2002-09-06 | Praecis Pharmaceuticals Incorporated | Methods for identifying peptides which modulate a biological process |
IL142481A0 (en) * | 2001-04-05 | 2002-03-10 | Yissum Res Dev Co | A method for identifying consitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof |
US20040142379A1 (en) | 2003-01-16 | 2004-07-22 | Carlsberg Research Laboratory | Affinity fishing for ligands and proteins receptors |
EP2098536A1 (de) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation und Identifikation antigen- oder ligandenspezifischer Bindungsproteine |
US10620185B2 (en) | 2015-02-27 | 2020-04-14 | Aptascan, Inc. | Molecular barcoded bi-stable switch |
WO2016138231A2 (en) | 2015-02-27 | 2016-09-01 | Sauder Timothy Lee | Molcular barcoded bi-stable switch |
US11739370B1 (en) | 2020-01-10 | 2023-08-29 | Gordian Biotechnology, Inc. | Methods and compositions for in vivo screening of therapeutics through spatial transcriptomics |
US20240150751A1 (en) * | 2021-04-26 | 2024-05-09 | Gordian Biotechnology, Inc. | Compositions and methods for in vivo screening of therapeutics using single nucleus sequencing |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1892296A1 (de) * | 1988-09-02 | 2008-02-27 | Dyax Corporation | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
DE4002897A1 (de) * | 1990-02-01 | 1991-08-08 | Behringwerke Ag | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
CA2114416C (en) * | 1991-08-07 | 1998-07-07 | W. French Anderson | Retroviral vectors containing internal ribosome entry sites |
US5395750A (en) * | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
WO1994018219A1 (en) * | 1993-02-02 | 1994-08-18 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
EP0689601B1 (de) * | 1993-02-22 | 2006-10-04 | The Rockefeller University | Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion |
WO1994020608A1 (en) * | 1993-03-12 | 1994-09-15 | Creighton University | Improved vectors for gene therapy |
WO1995004824A1 (en) * | 1993-08-05 | 1995-02-16 | Medvet Science Pty. Ltd. | Generation of dna libraries and retroviral vectors for same |
EP0725838A4 (de) * | 1993-10-26 | 1997-02-26 | United Biomedical Inc | Strukturierte synthetische antigenbanken als diagnostika, impfstoffe und therapeutische mittel |
-
1996
- 1996-05-31 DK DK96916019T patent/DK0832207T3/da active
- 1996-05-31 AU AU58933/96A patent/AU699568B2/en not_active Ceased
- 1996-05-31 WO PCT/DK1996/000231 patent/WO1996038553A1/en not_active Application Discontinuation
- 1996-05-31 KR KR1019970708636A patent/KR19990022157A/ko not_active Application Discontinuation
- 1996-05-31 AT AT96916019T patent/ATE196312T1/de not_active IP Right Cessation
- 1996-05-31 PT PT96916019T patent/PT832207E/pt unknown
- 1996-05-31 ES ES96916019T patent/ES2151167T3/es not_active Expired - Lifetime
- 1996-05-31 DE DE69610310T patent/DE69610310T2/de not_active Revoked
- 1996-05-31 EP EP96916019A patent/EP0832207B1/de not_active Revoked
- 1996-05-31 CA CA002222879A patent/CA2222879A1/en not_active Abandoned
- 1996-05-31 JP JP8536119A patent/JPH11505724A/ja not_active Ceased
- 1996-05-31 EP EP00201278A patent/EP1041143A3/de not_active Withdrawn
-
2000
- 2000-12-06 GR GR20000402708T patent/GR3035017T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0832207A1 (de) | 1998-04-01 |
AU5893396A (en) | 1996-12-18 |
CA2222879A1 (en) | 1996-12-05 |
ES2151167T3 (es) | 2000-12-16 |
EP1041143A2 (de) | 2000-10-04 |
EP0832207B1 (de) | 2000-09-13 |
PT832207E (pt) | 2001-03-30 |
WO1996038553A1 (en) | 1996-12-05 |
GR3035017T3 (en) | 2001-03-30 |
ATE196312T1 (de) | 2000-09-15 |
KR19990022157A (ko) | 1999-03-25 |
EP1041143A3 (de) | 2000-11-29 |
DE69610310T2 (de) | 2001-03-15 |
DK0832207T3 (da) | 2000-11-06 |
AU699568B2 (en) | 1998-12-10 |
JPH11505724A (ja) | 1999-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69610310D1 (de) | Verfahren zur identifikation von biologisch aktiven peptiden und nukleinsäuren | |
Fisch et al. | A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage. | |
Pavia et al. | The generation of molecular diversity | |
Sebestyén et al. | Chemical synthesis of peptide libraries | |
ES2124224T3 (es) | Metodo para escrutar genotecas recombinantes. | |
NO885659L (no) | Mycobakterielle rekombinanter og peptider. | |
ZA200201043B (en) | Novel B7-4 molecules and uses thereof. | |
GB9703369D0 (en) | Process | |
DE69837104D1 (de) | An g-protein gekoppelte rezeptoren und deren verwendungen | |
KR940703857A (ko) | 타이, 새로운 내피 세포 수용체 티로신 키나제(tie, a novel endothelial cell receptor tyrosine kinase) | |
ATE283359T1 (de) | Methode zum durchforsten von banken mittels chimären bindungspetiden | |
EP0270248A3 (en) | Dna useful for the transport of foreign proteins to the plant cell wall | |
ATE498013T1 (de) | Für zellzyklusproteine kodierende nukleinsäure und deren verwendung | |
EP1710299A3 (de) | Sekretierte Proteine und dafür kodierende Polynukleotide | |
AU8649698A (en) | Cell cycle-regulating proteins | |
DE69828874D1 (de) | Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
ES2133236A1 (es) | Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida. | |
Thomas et al. | Towards random polypeptide synthesis | |
WO2001090146A3 (en) | 57256 and 58289, human transporters and uses thereof | |
Weiss et al. | Genetic Methods in High-Resolution NMR Studies of Proteins | |
Snyder et al. | A CLUSTER OF DROSOPHILA CUTICLE GENES | |
Tucker | Purification, Crystallization, and Structural Determination of Wild Type Zebrafish Caspase-3 and the Utilization of a Novel M13 Bacteriophage System to Determine Substrate Specificity for Zebrafish Caspase-3. | |
DE69637484D1 (de) | Vektoren/DNA-Sequenzen aus humanen kombinatorischen Antikörper-Bibliotheken | |
DD272856A1 (de) | Verfahren zur simultansynthese von peptiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: INOXELL A/S, HORSHOLM, DK |
|
8331 | Complete revocation |